1. HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression
   Yan-Hong Zhou et al, 2020, Frontiers in Physiology CrossRef
2. Inflammation in myocardial injury- Stem cells as potential immunomodulators for myocardial regeneration and restoration
   Sajini Vadivel et al, 2020, Life Sciences CrossRef
3. Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis
   Stanislav Kotlyarov, 2022, International Journal of Molecular Sciences CrossRef
4. Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
   Raffaele Altara et al, 2017, Frontiers in Endocrinology CrossRef
5. Prostaglandin E2 EP receptors in cardiovascular disease: An update
   Timothy D. Bryson et al, 2022, Biochemical Pharmacology CrossRef
6. RETRACTED: MicroRNA-497 promotes proliferation and inhibits apoptosis of cardiomyocytes through the downregulation of Mfn2 in a mouse model of myocardial ischemia-reperfusion injury
   Lei Qin et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. Role of prostaglandin E2 in allogeneic mesenchymal stem cell therapy for cardiac repair
   Niketa Sareen et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
8. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases
   Yuanyuan Cheng et al, 2019, Expert Opinion on Therapeutic Targets CrossRef
9. LRRC15 expression indicates high level of stemness regulated by TWIST1 in mesenchymal stem cells
   Kensuke Toriumi et al, 2023, iScience CrossRef
10. Cerebro-Cardiovascular Diseases
    Walter Gottlieb Land, 2020, Damage-Associated Molecular Patterns in Human Diseases CrossRef